UCSF Dermatology Grand Rounds - 17 April 2024
Wednesday, April 17 at 8:10 am
-
10:15 am
Add to Calendar
2024-04-17 15:10:00
2024-04-17 17:15:00
UCSF Dermatology Grand Rounds - 17 April 2024
GRAND ROUNDS AND PATIENT VIEWINGReed LectureAutoinflammatory Skin DiseasesEdward W. Cowen, MD, MHSc, Chief, Dermatology Consultation Service, National Institute of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of HealthObjectives:1. Understand the common inflammatory pathways that underlie monogenic autoinflammatory diseases.
2. Recognize the cutaneous signs and internal organ systems affected by autoinflammatory diseases.
3. Develop a mechanism-based approach to management of autoinflammatory diseases.
Speaker Disclosures: Edward Cowen, MD has stated that she has no financial relationships to disclose.
Moderator Disclosures: Anna Haemel, MD has disclosed that she is an advisor or reviewer for CSL Behring, a consultant for Guidepoint LLC and receives a research grant from Priovant.
Planner Disclosures:
Ilona Frieden, MD has disclosed that she is a consultant for Venthera Bridgebio, Data Safety Monitoring Advisory Board for Pfizer, and Data Reviewer on the NCT02913612 Pediatric Trials
Network-NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01).
Kelly Cordoro, MD, Hunter Shain, PhD and Amanda Twigg, MD have stated they have no relationships to disclose.
1600 Divisadero Street
Herbst Hall Auditorium
San Francisco, CA 94115
United States
View on Map
Department Of Dermatology
Laura.Harrison@ucsf.edu
America/Los_Angeles
public
1600 Divisadero Street
Herbst Hall Auditorium
San Francisco, CA 94115
United States
View on Map
GRAND ROUNDS AND PATIENT VIEWING
Reed Lecture
Autoinflammatory Skin Diseases
Edward W. Cowen, MD, MHSc, Chief, Dermatology Consultation Service, National Institute of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health
Objectives:
1. Understand the common inflammatory pathways that underlie monogenic autoinflammatory diseases.
2. Recognize the cutaneous signs and internal organ systems affected by autoinflammatory diseases.
3. Develop a mechanism-based approach to management of autoinflammatory diseases.
Speaker Disclosures: Edward Cowen, MD has stated that she has no financial relationships to disclose.
Moderator Disclosures: Anna Haemel, MD has disclosed that she is an advisor or reviewer for CSL Behring, a consultant for Guidepoint LLC and receives a research grant from Priovant.
Planner Disclosures:
Ilona Frieden, MD has disclosed that she is a consultant for Venthera Bridgebio, Data Safety Monitoring Advisory Board for Pfizer, and Data Reviewer on the NCT02913612 Pediatric Trials
Network-NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01).
Kelly Cordoro, MD, Hunter Shain, PhD and Amanda Twigg, MD have stated they have no relationships to disclose.